Company intelligence / Profile preview

SomaticWell

Ownership: Private
Development stage: Commercial

Overview

SomaticWell provides personalized wellness and therapeutic services focused on neuroplasticity and somatic practices. The company specializes in supporting infants and children with neurodevelopmental conditions such as autism through non-pharmacological interventions including the Feldenkrais Method, Safe and Sound Protocol, HRV biofeedback, interactive meditation, and flower essences. These approaches aim to reduce anxiety, improve self-regulation of the autonomic nervous system, and foster personal transformation in a supportive environment[1].

Therapeutic areas: PsychiatryNeurology
Modalities: Non-pharmacological therapyBiofeedbackMovement therapyMind-body intervention
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on SomaticWell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SomaticWell.

Explore the full profile